These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 16566406)

  • 21. Symptomatic distal myopathy with cardiomyopathy due to a MYH7 mutation.
    Overeem S; Schelhaas HJ; Blijham PJ; Grootscholten MI; ter Laak HJ; Timmermans J; van den Wijngaard A; Zwarts MJ
    Neuromuscul Disord; 2007 Jun; 17(6):490-3. PubMed ID: 17383184
    [TBL] [Abstract][Full Text] [Related]  

  • 22. On genetic and phenotypic variability of hypertrophic cardiomyopathy: nature versus nurture.
    Marian AJ
    J Am Coll Cardiol; 2001 Aug; 38(2):331-4. PubMed ID: 11499720
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation into the use of plasma NT-proBNP concentration to screen for feline hypertrophic cardiomyopathy.
    Hsu A; Kittleson MD; Paling A
    J Vet Cardiol; 2009 May; 11 Suppl 1():S63-70. PubMed ID: 19395334
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structure-function relationships in myosin binding protein-C: taking off the blinders and collaring hypertrophic cardiomyopathy.
    Robbins J; Benson DW
    Circ Res; 2002 Oct; 91(8):656-8. PubMed ID: 12386140
    [No Abstract]   [Full Text] [Related]  

  • 25. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy.
    Christiaans I; Birnie E; Bonsel GJ; Wilde AA; van Langen IM
    Eur J Hum Genet; 2008 Oct; 16(10):1201-7. PubMed ID: 18478037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of hypertrophic cardiomyopathy in China.
    Cheng TO
    Chin Med J (Engl); 2004 Oct; 117(10):1600. PubMed ID: 15536665
    [No Abstract]   [Full Text] [Related]  

  • 27. The genetics of hypertrophic cardiomyopathy: Teare redux.
    Watkins H; Ashrafian H; McKenna WJ
    Heart; 2008 Oct; 94(10):1264-8. PubMed ID: 18653576
    [No Abstract]   [Full Text] [Related]  

  • 28. A molecular screening strategy based on beta-myosin heavy chain, cardiac myosin binding protein C and troponin T genes in Italian patients with hypertrophic cardiomyopathy.
    Girolami F; Olivotto I; Passerini I; Zachara E; Nistri S; Re F; Fantini S; Baldini K; Torricelli F; Cecchi F
    J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):601-7. PubMed ID: 16858239
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetic aspects of myocardial hypertrophy in hypertrophic cardiomyopathy and arterial hypertension].
    Smirnova MD; Fofanova TV; Postnov AIu; Ageev FT
    Ter Arkh; 2008; 80(1):77-84. PubMed ID: 18326235
    [No Abstract]   [Full Text] [Related]  

  • 30. Myosin binding protein C phosphorylation in normal, hypertrophic and failing human heart muscle.
    Jacques AM; Copeland O; Messer AE; Gallon CE; King K; McKenna WJ; Tsang VT; Marston SB
    J Mol Cell Cardiol; 2008 Aug; 45(2):209-16. PubMed ID: 18573260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy.
    Vasile VC; Ommen SR; Edwards WD; Ackerman MJ
    Biochem Biophys Res Commun; 2006 Jul; 345(3):998-1003. PubMed ID: 16712796
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.
    Alcalai R; Seidman JG; Seidman CE
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):104-10. PubMed ID: 17916152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apical hypertrophic cardiomyopathy or left ventricular non-compaction? A difficult differential diagnosis.
    Spirito P; Autore C
    Eur Heart J; 2007 Aug; 28(16):1923-4. PubMed ID: 17623677
    [No Abstract]   [Full Text] [Related]  

  • 34. Genetic basis of hypertrophic cardiomyopathy.
    Lind JM; Chiu C; Semsarian C
    Expert Rev Cardiovasc Ther; 2006 Nov; 4(6):927-34. PubMed ID: 17173506
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitochondrial complex I activity is significantly decreased in a patient with maternally inherited type 2 diabetes mellitus and hypertrophic cardiomyopathy associated with mitochondrial DNA C3310T mutation: a cybrid study.
    Chen J; Hattori Y; Nakajima K; Eizawa T; Ehara T; Koyama M; Hirai T; Fukuda Y; Kinoshita M; Sugiyama A; Hayashi J; Onaya T; Kobayashi T; Tawata M
    Diabetes Res Clin Pract; 2006 Nov; 74(2):148-53. PubMed ID: 16828917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypertrophic cardiomyopathy: current understanding and treatment objectives.
    Soor GS; Luk A; Ahn E; Abraham JR; Woo A; Ralph-Edwards A; Butany J
    J Clin Pathol; 2009 Mar; 62(3):226-35. PubMed ID: 18930982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apical hypertrophic cardiomyopathy and left ventricular non-compaction: two faces of the same disease.
    Monserrat L; Barriales-Villa R; Hermida-Prieto M
    Heart; 2008 Oct; 94(10):1253. PubMed ID: 18801786
    [No Abstract]   [Full Text] [Related]  

  • 38. Ubiquitin-proteasome system impairment caused by a missense cardiac myosin-binding protein C mutation and associated with cardiac dysfunction in hypertrophic cardiomyopathy.
    Bahrudin U; Morisaki H; Morisaki T; Ninomiya H; Higaki K; Nanba E; Igawa O; Takashima S; Mizuta E; Miake J; Yamamoto Y; Shirayoshi Y; Kitakaze M; Carrier L; Hisatome I
    J Mol Biol; 2008 Dec; 384(4):896-907. PubMed ID: 18929575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The clinical and social implications of mutation detection in patients with hypertrophic cardiomyopathy].
    Yang YJ; Fan CM
    Zhonghua Xin Xue Guan Bing Za Zhi; 2013 Aug; 41(8):716-8. PubMed ID: 24225248
    [No Abstract]   [Full Text] [Related]  

  • 40. The search of 'novel' mtDNA mutations in hypertrophic cardiomyopathy: MITOMAPping as a risk factor.
    Bandelt HJ; Yao YG; Salas A
    Int J Cardiol; 2008 Jun; 126(3):439-42. PubMed ID: 17482693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.